Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1987-08-28
1989-02-07
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
26050112, 26050118, 26050121, 514477, 514653, 514908, 558413, 558414, 558427, 560 5, 560252, 564341, 564366, 564387, 564391, 564413, 564426, C07C 622, C07C 8778
Patent
active
048032220
ABSTRACT:
The present invention relates to compounds of formula (I)
REFERENCES:
patent: 2530065 (1950-11-01), King
patent: 2574150 (1951-11-01), Kerwin et al.
patent: 3198802 (1965-08-01), Clark et al.
patent: 4511582 (1985-04-01), Bair
patent: 4530800 (1985-07-01), Bair
patent: 4532394 (1985-07-01), Bair
patent: 4551282 (1985-11-01), Bair
patent: 4719046 (1988-01-01), Bair
patent: 4719047 (1988-01-01), Bair
patent: 4719048 (1988-01-01), Bair
patent: 4719049 (1988-01-01), Bair
patent: 4719055 (1988-01-01), Bair
patent: 4720587 (1988-04-01), Bair
Investigational New Drugs 2, 1984, Bradley et al., pp. 54-90, "The Human Tumor Colony-Forming Chemosensitivity Array".
Dow Jones News Wire, 4/22/88 #160425-0097.
Hrabowska, M., et al., "Antitumor Activity of 1-Nitro-9 Amino Acidic Derivitives", Orgnin-Forsch./Drug Res. 32 (11), No. 9 (1982), 1013-1016.
Brown Donald
Burroughs Wellcome Co.
Covington Raymond
Hollrah Glennon H.
LandOfFree
Fluoranthene derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluoranthene derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluoranthene derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1085091